Related Experiment Video
Updated: May 2, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Differential effects of nitrostyrene derivatives on myelopoiesis involve regulation of C/EBPα and p38MAPK activity
Marije Bartels1, Andrana K Calgarotto2, Anton C Martens3
1Department of Cell Biology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Pediatrics, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract:
Bone marrow failure syndromes and MDS represent a heterogenous group of diseases, characterized by ineffective myelopoiesis, the risk of clonal evolution and a generally poor response to chemotherapy-based treatment regimen. Nitrostyrene derivatives have been studied as protein phosphatase inhibitors in various tumor models. Pharmacological studies have identified nitrostyrene as the structural core underlying a pro-apoptotic effect in tumor cells, yet their effects on normal cells, including those of the hematopoietic system, are largely unknown. In this study, utilizing umbilical cord blood-derived myeloid progenitor cells, patient-derived bone marrow cells, and a (BALB/c) mouse model; we investigated the effects of treatment with two nitrostyrene derivatives (NTS1 and NTS2) on myeloid development. We demonstrate that these compounds stimulate the expansion and differentiation of myeloid progenitors in vitro and improve myeloid reconstitution after chemotherapy-induced bone marrow depletion in vitro and in vivo. These effects were accompanied by increased C/EBPα expression and activity and inhibition of the p38MAPK signalling pathway. Together, our data suggest that nitrostyrenes improve myelopoiesis and represent potential new treatment strategies for patients suffering from bone marrow failure syndromes, hypocellular myelodysplastic syndrome and chemotherapy-induced aplasia.
Insights
Nitrostyrene derivatives show promise in treating bone marrow failure syndromes by enhancing myeloid progenitor cell expansion and differentiation. These compounds improve myeloid reconstitution after chemotherapy, offering new therapeutic avenues.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Bone marrow failure syndromes and myelodysplastic syndromes (MDS) are heterogeneous diseases with ineffective myelopoiesis and poor treatment responses.
- Nitrostyrene derivatives are known protein phosphatase inhibitors with pro-apoptotic effects in tumor cells, but their impact on normal hematopoietic cells is largely unknown.
Purpose of the Study:
- To investigate the effects of nitrostyrene derivatives (NTS1 and NTS2) on myeloid development.
- To evaluate their potential as therapeutic agents for bone marrow failure and related conditions.
Main Methods:
- Utilized umbilical cord blood-derived myeloid progenitor cells and patient-derived bone marrow cells.
- Employed a (BALB/c) mouse model for in vivo studies.
- Assessed myeloid progenitor expansion, differentiation, and hematopoietic reconstitution post-chemotherapy.
Main Results:
- Nitrostyrene derivatives stimulated myeloid progenitor expansion and differentiation in vitro.
- Compounds improved myeloid reconstitution in vivo after chemotherapy-induced bone marrow depletion.
- Observed increased C/EBPα expression/activity and p38MAPK pathway inhibition.
Conclusions:
- Nitrostyrenes enhance myelopoiesis and represent potential treatments for bone marrow failure syndromes, hypocellular MDS, and chemotherapy-induced aplasia.
- Further research into nitrostyrenes could lead to novel therapeutic strategies for hematologic disorders.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Differentiation of Common Myeloid Progenitor Cells

